Rolipram reduced tau phosphorylation, increased neuronal survival, normalized glial cell function, and inhibited cognitive decline by downregulating amyloid-β, amyloid precursor protein, and presenilin 1. This evidence concerns the gene MAPT and Mental deterioration.